STTKShattuck Labs, Inc.

Nasdaq shattucklabs.com


$ 10.60 $ 0.81 (8.28 %)    

Friday, 26-Apr-2024 15:59:43 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 10.59
$ 9.98
$ 0.00 x 0
$ 0.00 x 0
$ 9.94 - $ 10.64
$ 1.33 - $ 11.11
381,467
na
451.14M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-15-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-16-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 shattuck-labs-reports-preclinical-data-demonstrating-therapeutic-utility-of-trim7-inhibition-to-prevent-or-reverse-acquired-resistance-to-immune-checkpoint-therapy

These data were featured in an oral presentation during the AACR Annual Meeting 2024, being held from April 5-10, 2024, in San ...

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

 shattuck-labs-q4-eps-041-beats-057-estimate

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.57)...

 hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

 shattuck-labs-announces-50m-public-offering-of-common-stock-and-concurrent-private-placement-of-pre-funded-warrants

Shattuck Labs, Inc. ("Shattuck" or the "company") (NASDAQ:STTK), a clinical-stage biotechnology company pioneer...

 why-nxu-shares-are-trading-higher-by-around-42-here-are-20-stocks-moving-premarket

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining inv...

 dow-jumps-over-200-points-federal-reserve-holds-interest-rates-steady

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The...

 why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

 crude-oil-gains-15-blackboxstocks-shares-plummet

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 3...

 why-is-blood-cancer-focused-shattuck-labs-stock-soaring-today

Shattuck Labs Inc (NASDAQ: STTK) announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 i...

 us-stocks-mixed-producer-prices-unchanged-for-november

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday,...

Core News & Articles

STTK: 246% | Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION